Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Letters

• Publication date

  2003-05-08

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0304-3835(02)00699-7PMID 12706853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas

  2012cited by this paper
• Type IV collagenases in invasive tumors

  2005cited by this paper
• Identification of cis-acting promoter elements that support expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) in v-src transformed Madin–Darby canine kidney cells

  2004influential reference
• Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers

  2002cited by this paper
• The cell surface: the stage for matrix metalloproteinase regulation of migration.

  2002cited by this paper
• Adhesion assembly, disassembly and turnover in migrating cells – over and over and over again

  2002cited by this paper
• Matrix metalloproteinases: a tail of a frog that became a prince

  2002cited by this paper
• CD44 directs membrane‐type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin‐like domain

  2002cited by this paper
• Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.

  2002cited by this paper
• Oligomerization through Hemopexin and Cytoplasmic Domains Regulates the Activity and Turnover of Membrane-type 1 Matrix Metalloproteinase*

  2002cited by this paper
• An Alternative Processing of Integrin αv Subunit in Tumor Cells by Membrane Type-1 Matrix Metalloproteinase*

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Processing of Integrin αv Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion Kinase*

  2002cited by this paper
• The Hemopexin-like C-terminal Domain of Membrane Type 1 Matrix Metalloproteinase Regulates Proteolysis of a Multifunctional Protein, gC1qR*

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002influential reference
• Rac1 Mediates Type I Collagen-dependent MMP-2 Activation

  2001cited by this paper
• Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion

  2001influential reference
• Activation of the extracellular signal‐regulated protein kinase (ERK) cascade by membrane‐type‐1 matrix metalloproteinase (MT1‐MMP)

  2001cited by this paper
• Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis

  2001cited by this paper
• Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)

  2001cited by this paper
• Claudin Promotes Activation of Pro-matrix Metalloproteinase-2 Mediated by Membrane-type Matrix Metalloproteinases*

  2001cited by this paper
• Cytoplasmic tail–dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity

  2001influential reference
• Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

  2001cited by this paper
• Matrix metalloproteinases: they're not just for matrix anymore!

  2001cited by this paper
• Matrix-dependent Proteolysis of Surface Transglutaminase by Membrane-type Metalloproteinase Regulates Cancer Cell Adhesion and Locomotion*

  2001cited by this paper
• Cellular strategies for proteolytic targeting during migration and invasion

  2001cited by this paper
• Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration

  2001influential reference
• Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway

  2001cited by this paper
• The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

  2001cited by this paper
• Proteases in invasion: matrix metalloproteinases.

  2001cited by this paper
• Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.

  2001cited by this paper
• Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling*

  2001cited by this paper
• Membrane‐type 6 matrix metalloproteinase (MT6‐MMP, MMP‐25) is the second glycosyl‐phosphatidyl inositol (GPI)‐anchored MMP

  2000cited by this paper
• Functional activation of integrin αvβ3 in tumor cells expressing membrane‐type 1 matrix metalloproteinase

  2000cited by this paper
• Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3

  2000cited by this paper
• Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.

  2000cited by this paper
• Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2*

  2000cited by this paper
• Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.

  2000cited by this paper
• Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.

  2000cited by this paper
• Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5

  2000cited by this paper
• Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I.

  2000influential reference
• Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

  2000cited by this paper
• Significance of Membrane Type 1 Matrix Metalloproteinase Expression in Breast Cancer

  1999cited by this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999cited by this paper
• Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins*

  1999cited by this paper
• MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.

  1999cited by this paper
• Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

  1999cited by this paper
• Membrane Type 4 Matrix Metalloproteinase (MT4-MMP, MMP-17) Is a Glycosylphosphatidylinositol-anchored Proteinase*

  1999cited by this paper
• CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration

  1999cited by this paper
• Tissue Inhibitor of Metalloproteinases-3 Inhibits Shedding of L-selectin from Leukocytes*

  1999cited by this paper
• Furin-independent Pathway of Membrane Type 1-Matrix Metalloproteinase Activation in Rabbit Dermal Fibroblasts*

  1999cited by this paper
• Egr-1 Mediates Extracellular Matrix-driven Transcription of Membrane Type 1 Matrix Metalloproteinase in Endothelium*

  1999cited by this paper
• Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.

  1999cited by this paper
• Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

  1999cited by this paper
• Presence of high levels of MT1‐MMP protein in fibroblastic cells of human invasive carcinomas

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Membrane‐type matrix metalloproteinases

  1999cited by this paper
• The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.

  1998cited by this paper
• Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells.

  1998cited by this paper
• MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.

  1998cited by this paper
• Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

  1998cited by this paper
• Cancer: Proteases — invasion and more

  1998cited by this paper
• Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells*

  1998cited by this paper
• Prognostic values of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 expression in bladder cancer

  1998cited by this paper
• Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.

  1998influential reference
• Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.

  1998cited by this paper
• Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.

  1998cited by this paper
• Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis.

  1998cited by this paper
• Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells.

  1998cited by this paper
• Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: expression and morphogenetic correlation.

  1998cited by this paper
• Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

  1998cited by this paper
• Unaltered Secretion of β-Amyloid Precursor Protein in Gelatinase A (Matrix Metalloproteinase 2)-deficient Mice*

  1997cited by this paper
• Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion.

  1997cited by this paper
• Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin

  1997cited by this paper
• Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

  1997cited by this paper
• Expression of Matrix Metalloproteinases during Rat Skin Wound Healing: Evidence that Membrane Type-1 Matrix Metalloproteinase Is a Stromal Activator of Pro-Gelatinase A

  1997cited by this paper
• Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: Quantificative and morphological analyses

  1997cited by this paper
• Analysis of MT1‐MMP and MMP2 expression in human gastric cancers

  1997cited by this paper
• Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules*

  1997influential reference
• The Matrix Metalloproteinase-14 (MMP-14) Gene Is Structurally Distinct from Other MMP Genes and Is Co-expressed with the TIMP-2 Gene during Mouse Embryogenesis*

  1997influential reference
• MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells

  1997cited by this paper
• Increased expression of membrane type 1‐matrix metalloproteinase in head and neck carcinoma

  1997cited by this paper
• Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.

  1997cited by this paper
• MT-MMP expression and localisation in human lung and breast cancers

  1996cited by this paper
• Dual over‐expression pattern of membrane‐type metalloproteinase‐1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy

  1996cited by this paper
• Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*)

  1996influential reference
• Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.

  1996cited by this paper
• High level of MT‐MMP expression is associated with invasiveness of cervical cancer cells

  1996cited by this paper
• Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2

  1996cited by this paper
• Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation

  1996cited by this paper
• Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

  1996cited by this paper
• Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

  1996cited by this paper
• Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.

  1996cited by this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cited by this paper
• Membrane Type Matrix Metalloproteinase 1 Activates Pro-gelatinase A without Furin Cleavage of the N-terminal Domain*

  1996cited by this paper
• MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis.

  1996cited by this paper
• Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain.

  1995cited by this paper
• Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasis

  1995cited by this paper
• Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*)

  1995cited by this paper
• Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.

  1995cited by this paper

• Advances in the use of MT1-MMP-targeted nanobodies and peptides for therapeutic delivery in triple-negative breast cancer.

  2026cites this paper
• P21-activated kinase 4: a potent oncogene, molecular mechanisms and opportunities for targeted therapy

  2025cites this paper
• Engineering Vascularized Transplantable Soft Tissue Free Flaps in Sheep Using the Arteriovenous Loop Technique.

  2025cites this paper
• Investigation of MT1-MMP Activity in Cancer Cells.

  2024cites this paper
• Matrix Metalloproteinases on Skin Photoaging

  2024cites this paper
• Screening MT1-MMP Activity and Inhibition in Three-Dimensional Tumor Spheroids

  2023cites this paper
• Comparison of Decellularized Human Dermal Scaffolds versus Bovine Collagen/Elastin Matrices for Engineering of Soft-Tissue Flaps

  2023cites this paper
• Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance

  2023cites this paper
• Instrumental and transcriptome analysis reveals the chemotherapeutic effects of doxorubicin-loaded black phosphate nanosheets on abiraterone-resistant prostate cancer.

  2023cites this paper
• The first embryo, the origin of cancer and animal phylogeny. II. The neoplastic process as an evolutionary engine

  2023cites this paper
• Coordination of two kinesin superfamily motor proteins, KIF3A and KIF13A, is essential for pericellular matrix degradation by membrane-type 1 matrix metalloproteinase (MT1-MMP) in cancer cells

  2022cites this paper
• Combination of a Fluorescent Substrate-Based MMP Activity Assay and Hit Pick Reading/Imaging Procedure

  2022cites this paper
• Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression

  2022cites this paper
• Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu

  2022cites this paper
• Role of MMP-2 and CD147 in kidney fibrosis

  2022cites this paper
• Acoustic-Based Theranostic Probes Activated by Tumor Microenvironment for Accurate Tumor Diagnosis and Assisted Tumor Therapy.

  2022cites this paper
• The Neoplasia as embryological phenomenon and its implication in the animal evolution and the origin of cancer. II. The neoplastic process as an evolutionary engine

  2022cites this paper
• Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis

  2022cites this paper
• Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection

  2022cites this paper
• A multi-layered hybrid model for cancer cell invasion

  2022influential citation
• Bidirectional Mechanical Response Between Cells and Their Microenvironment

  2021cites this paper
• External stimuli-responsive nanomedicine for cancer immunotherapy

  2021cites this paper
• Combined Radiochemotherapy: Metalloproteinases Revisited

  2021cites this paper
• The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review

  2021cites this paper
• Dynamic Expression of Membrane Type 1-Matrix Metalloproteinase (Mt1-mmp/Mmp14) in the Mouse Embryo

  2021cites this paper
• Matrix metalloprotease-14 is a Target Enzyme for Detecting Peritoneal Metastasis in Gastric Cancer.

  2021cites this paper
• Overexpression of MMP14 predicts the poor prognosis in gastric cancer

  2021cites this paper
• Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy

  2021cites this paper
• Qualitative and Quantitative Analysis of Tumor Cell Invasion Using Au Clusters

  2021cites this paper
• Mechanical Cues Affect Migration and Invasion of Cells From Three Different Directions

  2020cites this paper
• Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process

  2020cites this paper
• MT1-MMP activatable fluorogenic probes with enhanced specificity via high-affinity peptide conjugation for tumor imaging.

  2020cites this paper
• An Activatable AIEgen Probe for High-Fidelity Monitoring of Overexpressed Tumor Enzyme Activity and Its Application to Surgical Tumor Excision.

  2020cites this paper
• Expression of MMP-14 and prognosis in digestive system carcinoma: a meta-analysis and databases validation

  2020cites this paper
• The Chemical Methods of Disulfide Bond Formation and Their Applications to Drug Conjugates

  2020cites this paper
• Inhibition of Ezrin suppresses cell migration and invasion in human nasopharyngeal carcinoma

  2019cites this paper
• MT1-MMP-dependent cell migration: proteolytic and non-proteolytic mechanisms

  2019cites this paper
• A DNA aptamer recognizing MMP14 for in vivo and in vitro imaging identified by cell-SELEX

  2019cites this paper
• MMP-14 degrades tropoelastin and elastin.

  2019cites this paper
• Recent developments in peptide-based SPECT radiopharmaceuticals for breast tumor targeting.

  2019cites this paper
• Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling

  2019cites this paper
• miR‐134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo

  2019cites this paper
• Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process

  2019cites this paper
• Assessment of the MT1-MMP expression level of different cell lines by the naked eye

  2018cites this paper
• The Immunohistochemical Expression of Matrix Metalloproteinases-2 and -9 in Low-Grade Appendiceal Mucinous Neoplasms: May These Neoplasms be Non-Invasive?

  2018cites this paper
• Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer

  2018cites this paper
• Potent and selective inhibition of matrix metalloproteinases by lanthanide trichloride

  2018cites this paper
• All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells

  2018cites this paper
• Nickel chloride administration prevents the growth of oral squamous cell carcinoma

  2018cites this paper
• Stable expression of α1-antitrypsin Portland in MDA-MB-231 cells increased MT1-MMP and MMP-9 levels, but reduced tumour progression.

  2018cites this paper
• The Precise Diagnosis of Cancer Invasion/Metastasis via 2D Laser Ablation Mass Mapping of Metalloproteinase in Primary Cancer Tissue.

  2018cites this paper
• miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis

  2017cites this paper
• Platelets and cancer angiogenesis nexus

  2017cites this paper
• EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression

  2017cites this paper
• Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition

  2017cites this paper
• New photodynamic molecular beacons (PMB) as potential cancer-targeted agents in PDT.

  2017cites this paper
• Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo

  2017cites this paper
• Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model

  2017cites this paper
• Lipidomics of Stem Cells

  2017cites this paper
• MT1-MMP Mediates the Migratory and Tumourigenic Potential of Breast Cancer Cells via Non-Proteolytic Mechanisms

  2017influential citation
• The Emerging Role of Sphingolipids in Cancer Stem Cell Biology

  2017cites this paper
• Regulation of human airway smooth muscle cell migration and relevance to asthma

  2017cites this paper
• Cleistanthin A inhibits the invasion and metastasis of human melanoma cells by inhibiting the expression of matrix metallopeptidase-2 and -9.

  2017cites this paper
• The cytoplasmic domain of MT1‐MMP is dispensable for migration augmentation but necessary to mediate viability of MCF‐7 breast cancer cells

  2017cites this paper
• MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.

  2017cites this paper
• Proteolytic Networks at the Crossroads of Cancer Cell Life and Death: Cancer Stem Cell Deciding Cell Fate

  2017cites this paper
• Distinct Protein Hydration Water Species Defined by Spatially Resolved Spectra of Intermolecular Vibrations

  2017cites this paper
• Collagen-Elastin and Collagen-Glycosaminoglycan Scaffolds Promote Distinct Patterns of Matrix Maturation and Axial Vascularization in Arteriovenous Loop–Based Soft Tissue Flaps

  2017cites this paper
• The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression

  2016cites this paper
• Emerging Designs of Activatable Photoacoustic Probes for Molecular Imaging.

  2016cites this paper
• TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion

  2016cites this paper
• Sunitinib treatment inhibited human breast cancer cell migration through regulation furin interaction with substrates

  2016cites this paper
• Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes

  2016cites this paper
• Pancreatic cancer stem cell markers and exosomes - the incentive push.

  2016cites this paper
• miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14

  2016cites this paper
• Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas

  2016cites this paper
• MicroRNA-524-5 p suppresses the growth and invasive abilities of gastric cancer cells

  2016influential citation
• PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.

  2016cites this paper
• MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.

  2016cites this paper
• Inhibition Of MT1-MMP Proteolytic Function And ERK1/2 Signalling Influences Breast Cancer Cell Migration And Invasion Through Changes In MMP-2 And MMP-9 Expression

  2016cites this paper
• Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expression

  2016cites this paper
• Comparison of MMP2 and MMP9 expression levels between primary and metastatic regions of oral squamous cell carcinoma.

  2016cites this paper
• Immunohistochemical demonstration of EphA2 processing by MT1-MMP in invasive cutaneous squamous cell carcinoma

  2016cites this paper
• Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells

  2016cites this paper
• In vivo sensing of proteolytic activity with an NSET-based NIR fluorogenic nanosensor.

  2016cites this paper
• Direct production of functional matrix metalloproteinase—14 without refolding or activation and its application for in vitro inhibition assays

  2016cites this paper
• MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction

  2016influential citation
• Matrix Metalloproteinases: From Structure to Function

  2015cites this paper
• Micro/Nano-Mechanical Cantilevers for Cancer Diagnosis

  2015cites this paper
• Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein.

  2015cites this paper
• Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.

  2015cites this paper
• miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.

  2015influential citation
• Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway

  2015cites this paper
• Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients

  2015cites this paper
• miR-181 suppresses metastasis via MMP-14

  2015cites this paper
• Effect of Matrine on HPAC cell migration by down-regulating the expression of MT1-MMP via Wnt signaling

  2015cites this paper
• Novel insights in the role of proteases during porcine fertilization in vitro

  2015cites this paper
• Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays.

  2015cites this paper
• 1 Matrix Metalloproteinases : From Structure to Function

  2015cites this paper
• Knockdown of WWP1 inhibits growth and invasion, but induces apoptosis of osteosarcoma cells.

  2015cites this paper